RION Announces the Advisory Appointments of John Ballantyne, Ph.D., to Chair of the Rion Scientific Advisory Board and Andrew D. Badley, M.D., to Chair of the Rion Medical Advisory Board

ROCHESTER, Minn.--(BUSINESS WIRE)-- #AgeDefying--RION, a clinical-stage regenerative medicine company with breakthrough platform technology leveraging platelet-derived exosomes, announces the appointment of Dr. Ballantyne as Chair of the company’s Scientific …

Visit Student Forum